This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Graft Versus Host Disease (GVHD)
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

This clinical trial studies biomarkers in predicting response in patients with graft-versus-host disease (GVHD) undergoing extracorporeal photopheresis (ECP). ECP treats the patient's blood with ultraviolet light outside the body and kills the white blood cells before returning blood back into the patient's body. Studying samples of blood from patients with GVHD may help doctors identify and learn more about biomarkers related to GVHD.

Provided treatments

  • Procedure: extracorporeal photopheresis
  • Other: laboratory biomarker analysis

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01324908. The sponsor of the trial is Vanderbilt-Ingram Cancer Center and it is looking for 85 volunteers for the current phase.
Official trial title:
T-regulatory Homing Subsets as a Predictor of Response in GVHD Treated With Extracorporeal Photopheresis